Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human PAK1 Antikörper:
anti-Mouse (Murine) PAK1 Antikörper:
anti-Rat (Rattus) PAK1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal PAK1 Primary Antibody für IHC - ABIN966797
Alexander, Yang, Hinds: Cellular senescence requires CDK5 repression of Rac1 activity. in Molecular and cellular biology 2004
Show all 3 Pubmed References
Human PAK1 Primary Antibody für IHC - ABIN966796
Thiel, Reeder, Pfaff, Coleman, Sells, Chernoff: Cell cycle-regulated phosphorylation of p21-activated kinase 1. in Current biology : CB 2002
Show all 3 Pubmed References
Human Polyclonal PAK1 Primary Antibody für WB - ABIN1944750
Brown, Stowers, Baer, Trejo, Coughlin, Chant: Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. in Current biology : CB 1997
Show all 3 Pubmed References
Human Polyclonal PAK1 Primary Antibody für ELISA, WB - ABIN188561
Zhao, Ma, Calon, Harris-White, Yang, Lim, Morihara, Ubeda, Ambegaokar, Hansen, Weisbart, Teter, Frautschy, Cole: Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. in Nature neuroscience 2006
Human Monoclonal PAK1 Primary Antibody für IF, IHC (p) - ABIN562102
Cook, Sanchez-Carbente, Lachance, Radzioch, Tremblay, Khandjian, DesGroseillers, Murai: Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus. in PLoS ONE 2011
Human Polyclonal PAK1 Primary Antibody für IF, IHC - ABIN362773
Rashid, Banerjee, Nikolic: Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. in The Journal of biological chemistry 2001
Show all 4 Pubmed References
Human Polyclonal PAK1 Primary Antibody für DB, IF - ABIN389799
El-Baba, Mahadevan, Fahlbusch, S, Rau, Gali-Muhtasib, Schneider-Stock: Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer. in Molecular cancer 2014
Human Polyclonal PAK1 Primary Antibody für ICC, IF - ABIN4343458
Geiger, Velic, Macek, Lundberg, Kampf, Nagaraj, Uhlen, Cox, Mann: Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse. in Molecular & cellular proteomics : MCP 2013
results represent the first evidence that Pak1 links extracellular signals to the genetic cascade of transcription factors necessary for cranial neural crest specification
These findings expand the role of phosphoinositides in kinase signaling and suggest how altered phosphoinositide metabolism may upregulate Pak1 activity in cancer cells.
The data suggest that EphA4 activation sequesters active Cdc42 (zeige CDC42 Antikörper) and in this way down-regulates cell-cell adhesion.
Pak1 inhibition interferes with the guidance of mesendoderm migration by directional cues residing in the extracellular matrix of the blastocoel roof, and with mesendoderm translocation in the embryo.
High expression of PAK1 is associated with invasion of gastric cancer.
Molecular modelling studies of PAK1 with its major interacting partners RHOA (zeige RHOA Antikörper) and STAT3 (zeige STAT3 Antikörper) revealed potential network gene elements in breast invasive carcinoma.
miR4855p reverses EMT (zeige ITK Antikörper) and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma. This study suggests that PAK1 plays an essential role in the progression of OSCC and it is a potential therapeutic target for OSCC.
Because reduced PAK1 activity impaired FA/BRCA function, inhibition of this kinase in PAK1 amplified and/or overexpressing breast cancer cells represents a plausible strategy for expanding the utility of PARP (zeige COL11A2 Antikörper) inhibitors to FA/BRCA-proficient cancers.
Overall, the authors find that p27 (zeige PAK2 Antikörper) directly promotes cell invasion by facilitating invadopodia turnover via the Rac1/PAK1/Cortactin (zeige CTTN Antikörper) pathway.
Results show that Pak1 is overexpressed in breast cancer cells and tissues, and found that Pak1 is a hormone responsive gene, whose expression can be modulated by steroid hormones, estrogen (E2) and progesterone (P4). Pak1 promoter analysis showed that PR mediates promoter activity via its binding to PRE present on the Pak1 promoter.
PAK1 confers TKI resistance in EGFR (zeige EGFR Antikörper)-mutant cells as well as in EGFR (zeige EGFR Antikörper)-wild-type cells.
Our findings offer an insight for the new drug development of PAK1 inhibitor. We also provide a possible explanation for the phenomenon that the application of the chlorhexidine in peritoneal lavage inhibited the development of tumor.
To our knowledge, this is the first study illustrating the mechanistic role of Pak1 in causing gemcitabine resistance via multiple signaling crosstalks, and hence Pak1-specific inhibitors will prove to be a better adjuvant with existing chemotherapy modality for pancreatic ductal adenocarcinoma (PDAC)
Studies indicate that PAK1 expression may be a predictive marker of overall survival and disease-specific survival in patients with solid tumors.
Depletion of active PAK1 up-regulates the immune system of APC (zeige APC Antikörper)(14/+) mice and suppresses intestinal tumour development. These observations suggest an important role for PAK1 in the immune response to tumours.
Because reduced PAK1 activity impaired FA/BRCA function, inhibition of this kinase in PAK1 amplified and/or overexpressing breast cancer cells represents a plausible strategy for expanding the utility of PARP (zeige PARP1 Antikörper) inhibitors to FA/BRCA-proficient cancers.
Results from our analysis showed that Pak1 overexpression, knockdown and Pak1 knockout cell line models showed that Pak1 confers protection to keratinocytes from UV-B-induced apoptosis and DNA damage via ATR
These results establish a novel signaling process whereby PAK1 upregulates COX-2 (zeige COX2 Antikörper), reduces anandamide levels and restricts tonic endocannabinoids-mediated processes.
The findings suggest that PAK1 deficiency may underlie an increased diabetic susceptibility. Discovery of ways to remediate glycaemic dysregulation via altering PAK1 or its downstream effectors offers promising opportunities for disease intervention.
present work presents the correlation between DSCAM gene overexpression and a dysregulation of the PAK pathway, resulting in altered morphological parameters of neuronal plasticity in the trisomic cell line, namely decreased number and length of processes
These results identify Pak1 and Pak2 (zeige PAK2 Antikörper) as redundant regulators of myoblast differentiation in vitro and in vivo and as components of the promyogenic Ncad (zeige CDH2 Antikörper)/Cdo (zeige CDO1 Antikörper)/Cdc42 (zeige CDC42 Antikörper) signaling pathway.
PAK-mediated phosphorylation of PKD1 at Ser203 triggers its membrane dissociation and subsequent entry into the nucleus, thereby regulating the phosphorylation of PKD1 nuclear targets, including class IIa histone deacetylases.
These results implicate PAK1 as a regulator of Pancreatic stellate cells activation, proliferation and apoptosis. Targeting stromal PAK1 could increase therapeutic response and survival of patients with pancreatic cancer.
The authors conclude that PAK1, besides its role in virus entry, also plays a relevant role in vaccinia virus dissemination.
FOXO-Pak1 pathway was recently shown to regulate mammalian neuronal polarity, our findings indicate that the roles of FOXO and Pak1 in neuronal migration are most likely conserved from C. elegans to higher organisms.
PAK1 promotes reproduction, whereas it inactivates HSP16.2 gene and shortens lifespan.
Pak-1 interacts with Wnt (zeige WNT2 Antikörper) signaling to regulate tissue polarity and gene expression.
only PAK-1 functions in the GIT/PIX (zeige ARHGEF7 Antikörper)/PAK pathway independently of RAC (zeige AKT1 Antikörper)/CDC42 (zeige CDC42 Antikörper) GTPases.
Data show that combined loss of ROCK and PAK, or ROCK and MRCK (zeige CDC42BPA Antikörper), completely prevented embryonic elongation, but a constitutively active form of MLC-4 could only rescue a lack of MRCK (zeige CDC42BPA Antikörper).
This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
p21 GTPase-associated kinase 1
, p21-activated kinase 1
, p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast)
, putative CDKN1A-activated kinase 1
, STE20 homolog, yeast
, p21/Cdc42/Rac1-activated kinase 1 (yeast Ste20-related)
, serine/threonine-protein kinase PAK 1
, CDC42/RAC effector kinase PAK-A
, activated protein kinase alpha
, p21 (CDKN1A)-activated kinase 1
, protein kinase MUK2